Is Pasireotide legal in the US?
Yes, FDA approved for Cushing's disease when surgery has not worked or is not possible.
AStrong human evidenceFDA approvedas of 2026-10-26
Approved. Pasireotide is sold as Signifor, a twice-daily subcutaneous injection, for adults with Cushing's disease for whom pituitary surgery is not an option or has not worked. A monthly long-acting form, Signifor LAR, is approved for acromegaly and for Cushing's disease. 2
Read the full Pasireotide page
More on Pasireotide
Citations
- Colao 2012, N Engl J Med: a 12-month phase 3 study of pasireotide in Cushing's disease doi.org
- Recordati Rare Diseases: Signifor (pasireotide) prescribing information recordatirarediseases.com
Reference information only, not medical advice. Drawn from the Pasireotide article, fact-checked against the cited sources. No dosing anywhere on this site.